110 results on '"Koca, Suleyman Serdar"'
Search Results
2. Effects of acute aerobic exercise on cytokines, klotho, irisin, and vascular endothelial growth factor responses in rheumatoid arthritis patients
Catalog
Books, media, physical & digital resources
3. Real-world data on change in work productivity, activity impairment, and quality of life in patients with psoriatic arthritis under anti-TNF therapy: a postmarketing, noninterventional, observational study
4. Tofacitinib and metformin reduce the dermal thickness and fibrosis in mouse model of systemic sclerosis
5. Case report: Pulmonary endarterectomy in Takayasu arteritis patient with group IV pulmonary hypertension: A rare clinical scenario
6. Extended Autoantibody Panel in Turkish Patients with Early-Stage Systemic Sclerosis: Co-expressions and Their Influences on Clinical Phenotypes
7. THE EFFECTS OF TELEREHABILITATION IN RHEUMATIC DISEASES DURING COVID-19 PANDEMIC.
8. Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry.
9. Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study).
10. Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study)
11. Extended autoantibody panel in Turkish patients with early‐stage systemic sclerosis: Coexpressions and their influences on clinical phenotypes
12. Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry
13. Cardiovascular Evaluation in Patients with Systemic Sclerosis in the Turkish Population
14. The first effect of COVID-19 pandemic on starting biological disease modifying anti-rheumatic drugs: outcomes from the TReasure real-life database
15. Does obesity affect treatment response to secukinumab and survival in ankylosing spondylitis? Real-life data from the TURKBIO Registry
16. Imaging of sacroiliac joints in patients with acromegaly
17. Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry
18. Treatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for Rheumatology
19. Serum adropin level and ENHO gene expression in systemic sclerosis
20. The IL-33 gene is related to increased susceptibility to systemic sclerosis
21. Investigation of the association between Rho/Rho-kinase gene polymorphisms and systemic sclerosis
22. A patient-reported outcome measures-based composite index (RAPID3) for the assessment of disease activity in ankylosing spondylitis
23. Serum IL-33 level and IL-33 gene polymorphisms in Behçet’s disease
24. Lapatinib Ameliorates Experimental Arthritis in Rats
25. Pemetrexed Ameliorates Experimental Arthritis in Rats
26. Real-world data on change in work productivity, activity impairment, and quality of life in patients with psoriatic arthritis under anti-TNF therapy: a postmarketing, noninterventional, observational study
27. Methodology of a new inflammatory arthritis registry: TReasure
28. Secukinumab and metformin ameliorate dermal fibrosis by decreasing tissue interleukin‐17 levels in bleomycin‐induced dermal fibrosis
29. COVID-19 Among Patients With Inflammatory Rheumatic Diseases
30. Impact of discordance between patient’s and evaluator’s global assessment on treatment outcomes in 14 868 patients with spondyloarthritis
31. Interim Analysis of Baseline Characteristics and Preferences of Administration Route of Rheumatoid Arthritis Patients Who Are Bio-Naive or Switched between Advanced RA Treatments; A Multicenter, Prospective, Observational Study
32. The 6-month drug survival rate in patients with rheumatoid arthritis treated with tofacitinib.
33. Corticosteroid Utilization before and after Initiation of Biologic Dmards between Patients with Rheumatoid Arthritis
34. Cigarette Smoking Does Not Affect Treatment Response to Tofacitinib in Rheumatoid Arthritis
35. Epigallocatechin 3‐gallate attenuates arthritis by regulating Nrf2, HO‐1, and cytokine levels in an experimental arthritis model
36. COVID-19 Among Patients With Inflammatory Rheumatic Diseases.
37. TÜRKBİO kayıt kütüğündeki romatoid artrit hastarında kötü prognostik faktörlerin araştırılması
38. Biyolojik ve hedefe yönelik sentetik ilaç tedavileri alan romatoid artritli hastalarda birlikte kullanılan metotreksat veya leflunomid tedavileri arasında fark var mı?
39. Epigallocatechin 3‐gallate attenuates arthritis by regulating Nrf2, HO‐1, and cytokine levels in an experimental arthritis model.
40. Resveratrol inhibits Src tyrosine kinase, STAT3, and Wnt signaling pathway in collagen induced arthritis model
41. Parotid abscess secondary to brucellosis in a patient with primary Sjögren's syndrome
42. Coexistence of Ankylosing Spondylitis and Neurofibromatosis Type 1
43. Low prevalence of obesity in Behçet’s disease is associated with high obestatin level
44. Carotid artery stiffness in Behçet’s disease
45. Changes in sirtuin 2 and sirtuin 3 mRNA expressions in rheumatoid arthritis
46. QT dispersion and P wave dispersion in patients with fibromyalgia
47. Resveratrol inhibits Src tyrosine kinase, STAT3, and Wnt signaling pathway in collagen induced arthritis model.
48. Hematological Indices May Be Useful in the Diagnosis of Systemic Lupus Erythematosus and in Determining Disease Activity in Behçet's Disease
49. The Protective Effects of Bevacizumab in Bleomycin-Induced Experimental Scleroderma
50. ENHO gene expression and serum adropin level in rheumatoid arthritis and systemic lupus erythematosus.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.